If you have PCOS, your glucose may be the missing link.

Up to 70% of women with PCOS have insulin resistance. When your cells stop responding properly to insulin, your body produces more of it, leading to higher glucose, hormonal imbalance, and fat storage that feels impossible to budge.

Signos helps you stabilize your glucose which is a major factor in reversing insulin resistance.
We're looking for women who want to influence how Signos expands its guidance, education, and support for women managing PCOS and insulin resistance.  

SIGNOS PUTS YOUR METABOLISM IN YOUR HANDS.

Signos pairs AI with a biosensor that turns raw glucose readings into real guidance. As the first FDA-cleared system of its kind for managing weight, Signos puts you in the metabolic driver's seat. 

GUIDANCE THAT ADAPTS
Signos learns your patterns and adjusts recommendations as your body changes.

CLARITY OVER TIME
See weekly insights that reveal trends and track your progress.

CHANGE THAT LASTS
Turn small shifts into lasting habits with guidance that fits your life.

NEW! SHAPE THE FUTURE
This exclusive opportunity to join the PCOS product panel is only open through November 7th.

How The Program Works

Invitation Only

Sign up for the waitlist and await your invitation as space becomes available. 

Expert Support & Coaching

Engage with in-app activities and a supportive community to keep you informed and accountable.

Glucose-Informed

Use Signos to stabilize your glucose and create habits to reverse insulin resistance. 

Share Your Feedback

Signos will send a survey after three months to gather feedback. You may be invited for a 1:1 interview. 

Join the waitlist for your exclusive invitation
to the PCOS product panel.

You'll receive a small discount as a thank you, plus opportunities to guide the product and even invitations for compensated interviews. Note: Invites are issued as space becomes available and spots are only guaranteed for three days. 

Home                          About                          Science                          How It Works                          FAQs                          Pricing                          Blog                          Support                          For Business                   

Copyright © 2025 Signos Inc.


Terms and Conditions

Privacy Policy

SIGNOS INDICATIONS: The Signos Glucose Monitoring System is an over-the-counter (OTC) mobile device application that receives data from an integrated Continuous Glucose Monitor (iCGM) sensor and is intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Signos Glucose Monitoring System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Signos Glucose Monitoring System may also help the user better understand how lifestyle and behavior modification, including diet and exercise, impact glucose excursions. This information may be useful in helping users to maintain a healthy weight.

The user is not intended to take medical action based on the device output without consultation with a qualified healthcare professional.

See user guide for important warnings and precautions.

STELO IMPORTANT INFORMATION: Consult your healthcare provider before making any medication adjustments based on your sensor readings and do not take any other medical action based on your sensor readings without consulting your healthcare provider. Do not use if you have problematic hypoglycemia. Failure to use Stelo and its components according to the instructions for use provided and to properly consider all indications, contraindications, warnings, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence. If your sensor readings are not consistent with your symptoms, a blood glucose meter may be an option as needed and consult your healthcare provider. Seek medical advice and attention when appropriate, including before making any medication adjustments and/or for any medical emergency.

STELO INDICATIONS FOR USE: The Stelo Glucose Biosensor System is an over-the-counter (OTC) integrated Continuous Glucose Monitor (iCGM) intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Stelo Glucose Biosensor System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Stelo Glucose Biosensor System may also help the user better understand how lifestyle and behavior modification, including diet and exercise, impact glucose excursion. The user is not intended to take medical action based on the device output without consultation with a qualified healthcare professional.

Home    About     Science    How It Works    FAQs
Pricing     Blog     Support     For Business     
Careers